Development
Tharimmune, Inc.
THAR
$1.51
-$0.0001-0.01%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.90M | 5.44M | 5.38M | 5.23M | 4.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.46M | 8.69M | 8.97M | 8.25M | 6.88M |
| Operating Income | -9.46M | -8.69M | -8.97M | -8.25M | -6.88M |
| Income Before Tax | -9.32M | -8.61M | -8.92M | -8.22M | -8.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.32 | -8.61 | -8.92 | -8.22 | -8.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.32M | -8.61M | -8.92M | -8.22M | -8.47M |
| EBIT | -9.46M | -8.69M | -8.97M | -8.25M | -6.88M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -13.09 | -16.21 | -18.19 | -17.82 | -18.94 |
| Normalized Basic EPS | -8.18 | -10.13 | -11.37 | -11.14 | -11.84 |
| EPS Diluted | -13.09 | -16.21 | -18.19 | -17.82 | -18.94 |
| Normalized Diluted EPS | -8.18 | -10.13 | -11.37 | -11.14 | -11.84 |
| Average Basic Shares Outstanding | 5.22M | 2.21M | 1.98M | 1.85M | 1.81M |
| Average Diluted Shares Outstanding | 5.22M | 2.21M | 1.98M | 1.85M | 1.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |